Review Article

Published in:
Volume 5 / Year 2016 / Issue 1

Life begins at forty – hybridomas: ageing technology holds promise for future drug discoveries

Page: 21-6

Abstract: Hybridomas were developed in 1975 as a stable platform for creating monoclonal antibodies (mAbs). Over the past 40 years, hybridomas have been a leading platform for creating mAbs, yet… Read More »

Go Back Print